[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360470-105":59,"doc-detail-360470-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","trmt112-drives-a-tumor-growth-and-metastasis-promoting-program-in-triple-negative-breast-cancer","TRMT112 drives a tumor growth and metastasis-promoting program in triple-negative breast cancer","","Ribosomal RNA modifying proteins (RRMPs) regulate post-transcriptional rRNA modifications that shape ribosome biogenesis, translation fidelity, and efficiency. Multi-omics profiling of 22 RRMPs across cancers using large public genomic resources revealed widespread genomic and transcriptional dysregulation, with triple-negative breast cancer showing the strongest RRMP enrichment and worse survival. TRMT112 was identified as a key driver. Knockdown reduced TNBC proliferation, migration, invasion, and metastatic potential, while overexpression enhanced tumorigenic phenotypes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/trmt112-drives-a-tumor-growth-and-metastasis-promoting-program-in-triple-negative-breast-cancer/360470/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/trmt112-drives-a-tumor-growth-and-metastasis-promoting-program-in-triple-negative-breast-cancer/360470.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role do ribosomal RNA modifying proteins (RRMPs) play in cancer?","Question",{"text":113,"@type":114},"RRMPs execute rRNA post-transcriptional modifications that influence ribosome biogenesis and protein synthesis. Their dysregulation is linked to tumorigenicity, progression, and patient outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why is TRMT112 important in triple-negative breast cancer (TNBC)?",{"text":118,"@type":114},"TRMT112 is essential for breast cancer cell survival and is highly enriched in aggressive subtypes, especially TNBC. Its overexpression associates with poor clinical outcomes.",{"name":120,"@type":111,"acceptedAnswer":121},"How does TRMT112 affect tumor growth and metastasis?",{"text":122,"@type":114},"TRMT112 knockdown in TNBC cells significantly reduces proliferation, migration, invasion, and metastatic potential, while overexpression increases these tumorigenic traits.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},360470,1790823592,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/cdd](www.nature.com/cdd)  \nARTICLE OPEN   \nTRMT112 drives a tumor growth and metastasis-promoting program in triple-negative breast cancer  \nAmr R. Elhamamsy 1, Brandon J. Metge 1, Mohamed H. Elbahoty1, Bhavyasree Papineni 1, Heba Allah M. Alsheikh1, Dongquan Chen2,3, Rajeev S. Samant 1,3 and Lalita A. Shevde1,3 ✉  \n© The Author(s) 2025  \n\n|  | Ribosomal RNA Modifying Proteins (RRMPs) are integral to ribosome biogenesis, executing post-transcriptional modiﬁcations that inﬂuence translation ﬁdelity and efﬁciency. Dysregulation of RRMPs has been increasingly implicated in cancer progression, yet their collective role across malignancies remains largely unexplored. Here, we performed a multi-omics analysis of 22 RRMPs across diverse cancer types using The Cancer Genome Atlas, the Molecular Taxonomy of Breast Cancer International Consortium, and additional high-throughput datasets. Our analysis revealed widespread genomic alterations and transcriptional dysregulation of RRMPs across malignancies, with distinct expression patterns in breast cancer subtypes. Notably, Triple-Negative Breast Cancer (TNBC) exhibited the highest RRMPs enrichment, which correlated with increased genomic instability including elevated tumor mutational burden and aneuploidy scores, and poor survival outcomes. Among the RRMPs, tRNA methyltransferase activator subunit 11-2 (TRMT112) emerged as a key regulator of tumor progression. Functional assays demonstrated that TRMT112 knockdown in TNBC cells signiﬁcantly reduced proliferation, migration, invasion, and metastatic potential, whereas its overexpression enhanced these tumorigenic properties. Polysome proﬁling and RNA sequencing of actively translated transcripts revealed that TRMT112 reprograms the translational landscape by promoting pro-metastatic and stromal remodeling pathways while suppressing immune-related processes. In vivo studies using an orthotopic breast cancer model further conﬁrmed that TRMT112 depletion impairs tumor growth and reduces metastatic burden. Collectively, our ﬁndings establish RRMPs as critical modulators of cancer progression and identify TRMT112 as a key driver of aggressive phenotypes in TNBC. The dysregulation of TRMT112 across breast cancer subtypes highlights its potential as both a prognostic biomarker and a therapeutic target. These insights provide a mechanistic foundation for future interventions aimed at targeting TRMT112-driven translational programs in |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| aggressive breast cancer. |  |  |\n|  | Cell Death & Differentiation (2026) 33:1192–1202; [https://doi.org/10.1038/s41418-025-01643-z](https://doi.org/10.1038/s41418-025-01643-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe landscape of cancer biology is markedly inﬂuenced by dynamic alterations in ribosomal RNA (rRNA), which plays a pivotal role in cellular function and organismal physiology [1, 2] . Among the multifarious factors contributing to the complexity of cancer, Ribosomal RNA Modifying Proteins (RRMPs) are gaining prominence due to their intricate involvement in the modiﬁcation of rRNA, essential for ribosome biogenesis and function [3–5] . However, despite their fundamental roles, little is known about the speciﬁc contributions of RRMPs to cancer biology, and their potential as therapeutic targets remains underexplored.  \nRRMPs are not mere participants in the translational machinery but are central to the post-transcriptional modiﬁcations that govern the fate of rRNA, impacting everything from peptide bond formation to the ﬁdelity of protein synthesis [6, 7] . Dysregulation of RRMPs is increasingly recognized as a determinant of tumorigenicity, inﬂuencing cancer onset, progression, and patient outcomes [8–10] . Genetic alterations in RRMPs, ranging from mutations to copy number variations, have been ","cbCaiciTncZQ0xTb","https://ap.wps.com/l/cbCaiciTncZQ0xTb","pdf",8647238,11,"English","# Introduction\n## RRMPs in cancer biology\n## TRMT112 enrichment and clinical relevance","[{\"question\":\"What role do ribosomal RNA modifying proteins (RRMPs) play in cancer?\",\"answer\":\"RRMPs execute rRNA post-transcriptional modifications that influence ribosome biogenesis and protein synthesis. Their dysregulation is linked to tumorigenicity, progression, and patient outcomes.\"},{\"question\":\"Why is TRMT112 important in triple-negative breast cancer (TNBC)?\",\"answer\":\"TRMT112 is essential for breast cancer cell survival and is highly enriched in aggressive subtypes, especially TNBC. Its overexpression associates with poor clinical outcomes.\"},{\"question\":\"How does TRMT112 affect tumor growth and metastasis?\",\"answer\":\"TRMT112 knockdown in TNBC cells significantly reduces proliferation, migration, invasion, and metastatic potential, while overexpression increases these tumorigenic traits.\"}]","TRMT112 drives a tumor growth and metastasis-promoting program in triple-negative breast cancer | PDF",1790140208,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7cceb8a11172ff711836f4e59d69414.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da564892f7bbc71981f80117a56b8a90.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fa566b570d72739afc4db22621250d9.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a3b467f36165fb0d380e5e1bc979fc7.webp",980,1301]